David R. Jayne

guest is the first author of Clinical and Biomarker Responses to BI 655064, an Antagonistic Anti-CD40 Antibody, in Patients With Active Lupus Nephritis: A Randomized, Double-Blind, Placebo-Controlled, Phase II Trial

Best podcasts with David R. Jayne

Ranked by the Snipd community

Feb 6, 2024 • 33min

The Power of the Negative Study

Dr. David R. Jayne discusses his study on an anti-CD40 antibody in lupus nephritis, highlighting the power of negative studies. They talk about challenges in conducting trials, measurement of anti-drug antibodies, embracing failures in science, and the importance of publishing negative results.